Hepion Pharmaceuticals share price logo

Hepion Pharmaceuticals

OTC: HEPA

$0.08

-0.02

(-19.00%)

as on

Hepion Pharmaceuticals Stock Performance

as on October 3, 2026 at 6:41 am IST

  • Day's Low

    Day's High

    $0.08
    $0.10
    downward going graph

    1.23%

    Downside

    23.46%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.03
    $0.12
    downward going graph

    57.90%

    Downside

    51.23%

    Upside

    downward going graph

Hepion Pharmaceuticals share price movements today

Previous Close
$0.10
Open
$0.10
Volume
1.2M
Market Cap
$7.3M
Day's Low - High
$0.08 - $0.10
52 Week Low - High
$0.03 - $0.12

Hepion Pharmaceuticals Historical Returns

1 Month Return
-7.95 %
3 Month Return
-3.23 %
1 Year Return
+ 17.73 %
3 Year Return
-99.96 %
5 Year Return
-99.99 %

Hepion Pharmaceuticals Stock Fundamentals & Key Indicators

Check Hepion Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.3M

EPS (TTM)

-0.2436

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.33

Industry PE ratio

-3.89

PEG Ratio

-0.00

EBITDA

-2.8M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-139.73%

Hepion Pharmaceuticals stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Hepion Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$7.3M-99.99%-0.330.00%0.00%

Stock Returns calculator for Hepion Pharmaceuticals Stock including INR - Dollar returns

The Hepion Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Hepion Pharmaceuticals investment value today

Current value as on today

₹1,27,780

Returns

₹27,780

(+27.78%)

Returns from Hepion Pharmaceuticals Stock

₹17,733 (+17.73%)

Dollar Impact

₹10,047 (+10.05%)

Analyst Recommendation on Hepion Pharmaceuticals Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Hepion Pharmaceuticals. Average target price of $30

Hepion Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Hepion Pharmaceuticals.

What analysts predicted

99.73%UPSIDE

Target Price

$30

Current Price

$0.081

Analyzed by

8 Analysts

Target

$30.00

Hepion Pharmaceuticals target price $30, a slight upside of 99.73% compared to current price of $0.081. According to 8 analysts rating.

Hepion Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-5
-8
-4
-1
-1
-1
0
0
0
-1
EBITDA
-5
-3
-3
4
-6
-1
0
0
0
-1
Interest Expense
0
-
0
0
0
-
0
0
0
-
Depreciation
0
-
0
0
-
0
0
-
-
-
Income Before Tax
-5
-3
-4
-1
-6
-1
0
0
0
-1
Income Tax Expense
-2
-
-
-
-
-
-
-
-
-
Net Income
-2
-3
-4
-1
-6
-1
0
0
0
-1
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Hepion Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
-
-
-
-
-
-
Operating Income
-21
-14
-7
-20
-30
-45
-48
-19
-4
EBITDA
-20
-14
-7
-20
-32
-44
-49
-14
-3
Interest Expense
-
0
0
0
0
0
0
1
0
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-18
-9
-7
-20
-32
-45
-49
-16
-8
Income Tax Expense
-3
0
0
0
-
-2
0
-2
-
Net Income
-15
-9
-7
-20
-32
-42
-48
-13
-8
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Hepion Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-2
-3
-4
-1
-6
-1
0
0
0
-1
Operating Cash Flow
-3
-10
-2
-1
-1
-1
0
0
0
-1
Investing Cash Flow
-
-
0
-
-
0
-
-
-
-
Financing Cash Flow
1
-
2
-
5
0
0
0
0
0
Change in Cash
-1
-10
0
-1
4
-1
0
0
0
0

Hepion Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-15
-9
-7
-20
-32
-42
-48
-13
-8
Operating Cash Flow
-8
-15
-7
-16
-31
-34
-40
-18
-3
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
1
12
18
43
81
-5
4
4
4
Change in Cash
-1
-3
11
26
50
-40
-36
-14
1

Global Institutional Holdings in Hepion Pharmaceuticals

Check out the Institutions with significant holdings in Hepion Pharmaceuticals.

Funds
Holdings
XTX Topco Ltd
0.00%
Anson Funds Management LP
0.43%
BlackRock Inc
0.15%
Vanguard Group Inc
0.09%
Geode Capital Management, LLC
0.08%

About Hepion Pharmaceuticals

Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is dedicated to developing therapeutic interventions for chronic hepatic ailments. Central to their efforts is Rencofilstat, a cyclophilin inhibitor that has successfully concluded Phase 2a clinical trials. This compound operates by disrupting multiple pathological pathways implicated in the worsening of liver disease. It is currently progressing through clinical development for non-alcoholic steatohepatitis (NASH) and is additionally being explored in nonclinical research for its potential to reduce liver fibrosis and lessen hepatocellular carcinoma tumor loads in experimental models of NASH. Moreover, Rencofilstat has exhibited antiviral properties against hepatitis B, C, and D viruses through diverse mechanisms. The company, established in 2013 and situated in Edison, New Jersey, rebranded as Hepion Pharmaceuticals, Inc. in July 2019, having previously operated as ContraVir Pharmaceuticals, Inc.
OrganisationHepion Pharmaceuticals
Headquarters55 Madison Avenue, Morristown, NJ, 07960, US
IndustryBiotechnology
CEOGary S. Stetz

Key Management of Hepion Pharmaceuticals

Name

Title

Mr. Vincent LoPriore

Executive Chairman

Mr. Gary S. Stetz CPA

Interim CEO & Director

Sharen Pyatetskaya

Director of Investor Relations

FAQs

What is Hepion Pharmaceuticals share price today?

Hepion Pharmaceuticals share price today is $0.08 as on at the close of the market. Hepion Pharmaceuticals share today touched a day high of $0.10 and a low of $0.08.

What is the 52 week high and 52 week low for Hepion Pharmaceuticals share?

Hepion Pharmaceuticals share touched a 52 week high of $0.12 on and a 52 week low of $0.03 on . Hepion Pharmaceuticals stock price today i.e. is closed at $0.08,which is 33.88% down from its 52 week high and 137.54% up from its 52 week low.

What is Hepion Pharmaceuticals's market capitalisation today?

Hepion Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in Hepion Pharmaceuticals Stock (HEPA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Hepion Pharmaceuticals on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Hepion Pharmaceuticals Stock (HEPA) from India?

Indian investors can start investing in Hepion Pharmaceuticals (HEPA) shares with as little as ₹96.292503356934 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹962.93 in Hepion Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on Hepion Pharmaceuticals share’s latest price of $0.08 as on October 3, 2026 at 1:11 am IST, you will get 123.4568 shares of Hepion Pharmaceuticals. Learn more about fractional shares .

What are the returns that Hepion Pharmaceuticals has given to Indian investors in the last 5 years?

Hepion Pharmaceuticals stock has given -99.99% share price returns and 29.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?